MULTIPLE SCLEROSIS
![Foto de MULTIPLE SCLEROSIS](/img/grupo.png)
![Foto de Universidad de Cantabria](/img/noimage_org.png)
Universidad de Cantabria
Santander, EspañaPublications in collaboration with researchers from Universidad de Cantabria (1)
2021
-
Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study
Frontiers in Immunology, Vol. 12